What the Health? From KFF Health News: Turnarounds and Shake-Ups
The Host Mary Agnes Carey KFF Health News @maryagnescarey Read Mary Agnes’ stories. The midterm…
What the Health? From KFF Health News: Turnarounds and Shake-Ups
The Host Mary Agnes Carey KFF Health News @maryagnescarey Read Mary Agnes’ stories. The midterm elections are months away, yet changes at the Department of Health and Human Services suggest the Trump administration is focusing on how to win on health care, which remains a top concern for voters. Facing growing concern about the administration’s…
Intrauterine Devices (IUDs): Access and Coverage in the U.S.
Intrauterine devices (IUDs), along with implants, are known as long-acting reversible contraception (LARCs) because they can be used to prevent pregnancy for several years. This fact sheet reviews FDA-approved IUDs, as well as use, availability, and key issues in insurance coverage and financing of IUDs in the U.S.
Sustaining Clinician Independence: Why Simplicity, Not Consolidation, Is Key to Solving the Mental Health Crisis
Instead of adding more layers of complexity to an already strained system, there’s a more effective solution: make it simpler for independent clinicians to run a practice, participate in insurance networks directly, coordinate care, and provide treatment. The post Sustaining Clinician Independence: Why Simplicity, Not Consolidation, Is Key to Solving the Mental Health Crisis appeared…
Imaging Data Liquidity: The Foundation of Multimodal Medical Intelligence
Imaging has become a core input into how health systems understand disease, evaluate outcomes, plan capacity, and increasingly, how they learn. The post Imaging Data Liquidity: The Foundation of Multimodal Medical Intelligence appeared first on MedCity News.
Anthropic: It’s “Critical” To Bring Company Products to EHR
The head of Anthropic’s biology and life sciences business spoke about introducing “first-party” products, having a presence inside the EHR and what Claude can do for rural hospitals. The post Anthropic: It’s “Critical” To Bring Company Products to EHR appeared first on MedCity News.
Nevada Debuts Public Option Amid Tumultuous Federal Changes to Health Care
More than 10,000 people have enrolled in Nevada’s new public option health plans, which debuted last fall with the expectation that they would bring lower prices to the health insurance market. Those preliminary numbers from the open enrollment period that ended in January are less than a third of what state officials had projected. Nevada…
An Arm and a Leg: Personal Finance Guru Faces Down an Insurance Denial
Less than 36 hours before his wife was scheduled to undergo major surgery, New York Times personal finance columnist Ron Lieber got an unwelcome letter from his family’s insurance plan: It was denying prior authorization for the procedure. With no time to lodge an appeal, Lieber and his wife decided to proceed and bet on…
Decoding the PBM Reform Provisions of the 2026 Consolidated Appropriations Act
After years of legislative debate, Congress has formally codified PBM reform into federal statute. Tucked within the Consolidated Appropriations Act, 2026 (H.R. 7148), signed on February 3, 2026 are structural mandates that will reshape Pharmacy Benefit Manager (PBM) operations in Medicare Part D and the commercial sector by 2028. The legislation targets three primary pillars:…
Solera Health Launches Behavioral Health Network with Calm and Lyra
Solera Health has launched a behavioral health network that connects members to partners Calm Health and Lyra Health for digital mental health, coaching and therapy services. The post Solera Health Launches Behavioral Health Network with Calm and Lyra appeared first on MedCity News.
Eli Lilly Joins Chase for Hot Inflammation Target, Paying $100M for Rights to CSL Drug
CSL Limited retain rights to clazakizumab in end-stage kidney disease. Eli Lilly gets rights to the the IL-6-blocking antibody in other indications that could put it in competition with Novo Nordisk and Novartis. The post Eli Lilly Joins Chase for Hot Inflammation Target, Paying $100M for Rights to CSL Drug appeared first on MedCity News.
